methionyl-tRNA synthetase inhibitors (Trius Therapeutics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namemethionyl-tRNA synthetase inhibitors (Trius Therapeutics)
Drug Alias NameRX-100472
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial proteins synthesis inhibitorsMethionyl-tRNA synthetase inhibitors
TargetsBacterial proteinsMethionyl-tRNA synthetase
Therapy Area/IndicationsGram-Positive Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTrius Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTrius Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsGram-Positive Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A